thiazolidines has been researched along with pioglitazone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Kurosaki, E; Nakano, R; Shibasaki, M; Shikama, H; Shimaya, A; Shioduka, K | 1 |
| Awano, K; Kinoshita, S; Maeda, T; Miyachi, H; Murakami, K; Nomura, M; Satoh, H; Tsunoda, M | 1 |
| Hase, T; Kawahito, Y; Mitsuhashi, M; Nakatani, T; Sano, H; Segawa, Y; Wada, S; Yoshimura, R | 1 |
| Fujita, H; Hirose, H; Kawai, T; Miyashita, K; Ogawa, T; Saruta, T; Seto, Y; Ukeda, K; Yajima, K; Yamada, T; Yamamoto, Y | 1 |
| Narce, M; Poisson, JP | 1 |
| Dorais, M; LeLorier, J | 1 |
| Bassett, K; Carleton, B; Carney, G; Dormuth, CR; Wright, JM | 1 |
| Chaudhary, S; Dube, A; Kothari, V; Sachan, N; Upasani, CD | 1 |
| Bhutani, R; Bodla, RB; Kant, R; Kapoor, G | 1 |
| Kaminskyy, D; Khyluk, D; Kryshchyshyn-Dylevych, A; Lesyk, R; Skóra, B; Szychowski, KA | 1 |
| Asati, V; Baweja, GS; Gupta, S; Irani, M; Singh, R; Singh, S | 1 |
11 other study(ies) available for thiazolidines and pioglitazone
| Article | Year |
|---|---|
YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Animals; Biological Transport; Carrier Proteins; Cell Differentiation; Deoxyglucose; Dose-Response Relationship, Drug; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Gene Expression; Genes, Reporter; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Inositol 1,4,5-Trisphosphate; Insulin; Mice; Monocytes; Monosaccharide Transport Proteins; Muscle Proteins; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Phosphatidylinositol 3-Kinases; Pioglitazone; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Triglycerides; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1998 |
(3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents.
Topics: Animals; Blood Glucose; Hypoglycemic Agents; Insulin; Mice; Mice, Obese; Pioglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Thiazolidines; Triglycerides | 1999 |
Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Chromans; Dinoprostone; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Immunohistochemistry; Ligands; Male; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Testicular Neoplasms; Testis; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2002 |
Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
Topics: Animals; Bezafibrate; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Glucose; Glucose Transporter Type 2; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Monosaccharide Transport Proteins; Pancreas; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors | 2003 |
Novel PPARgamma-dependent and independent effects for thiazolidinediones.
Topics: Animals; Bezafibrate; Body Weight; Chromans; Diabetes Mellitus, Type 2; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Mice; Monocytes; Pancreas; Pioglitazone; PPAR alpha; PPAR gamma; Pregnancy Proteins; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Troglitazone; Tumor Necrosis Factor-alpha | 2003 |
Impact of the socioeconomic status on the probability of receiving formulary restricted thiazolidine (TZDs).
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus, Type 2; Drug Prescriptions; Female; Formularies as Topic; Humans; Hypoglycemic Agents; Insurance, Health, Reimbursement; Insurance, Pharmaceutical Services; Male; Medical Records Systems, Computerized; Middle Aged; Pioglitazone; Quebec; Retrospective Studies; Risk Factors; Rosiglitazone; Socioeconomic Factors; Thiazolidinediones; Thiazolidines | 2008 |
Thiazolidinediones and fractures in men and women.
Topics: Adult; Aged; British Columbia; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Female; Fractures, Spontaneous; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Proportional Hazards Models; Prospective Studies; Risk; Rosiglitazone; Sex Factors; Sulfonylurea Compounds; Thiazolidinediones; Thiazolidines | 2009 |
NS-1: a novel partial peroxisome proliferator-activated receptor γ agonist to improve insulin sensitivity and metabolic profile.
Topics: Adipocytes; Adipogenesis; Animals; Body Weight; Glucose Tolerance Test; Insulin Resistance; Male; Metabolome; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Pioglitazone; PPAR gamma; Thiazolidinediones; Thiazolidines | 2012 |
Optimization of a single HPLC-PDA method for quantifying Metformin, Gliclazide, Pioglitazone, Dapagliflozin, Empagliflozin, Saxagliptin, Linagliptin and Teneligliptin using central composite design.
Topics: Adamantane; Benzhydryl Compounds; Chromatography, High Pressure Liquid; Dipeptides; Dose-Response Relationship, Drug; Gliclazide; Glucosides; Linagliptin; Metformin; Molecular Structure; Pioglitazone; Pyrazoles; Software; Structure-Activity Relationship; Thiazolidines | 2019 |
4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines.
Topics: A549 Cells; Antioxidants; Apoptosis; Caco-2 Cells; Caspase 3; Cell Line; Cell Line, Tumor; Humans; Neoplasms; Oxidative Stress; Pioglitazone; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Thiazolidines | 2021 |
Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: Design, synthesis and in vivo studies.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Design; Hypoglycemic Agents; Mice; Molecular Docking Simulation; Pioglitazone; PPAR gamma; Thiazolidinediones; Thiazolidines; Zebrafish | 2023 |